Distribution of NOS isoforms in a porcine endotoxin shock model

Shock

Volumn 29, Issue 6, 2008, Pages 692-702

  Doursout, Marie Francoise ^a   Oguchi, Takeshi ^a   Fischer, Uwe M ^a   Liang, Yangyan ^a   Chelly, Brice ^a   Hartley, Craig J ^b   Chelly, Jacques E ^c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cardiac function; NOS isoforms; Porcine endotoxin model; Regional blood flow; Septic shock

Indexed keywords

AMINOGUANIDINE; ARGININE DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY BLOOD VESSEL; DISEASE MODEL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; HEART; HEMODYNAMICS; KIDNEY; LARGE INTESTINE; LIVER; LUNG; MESENTERY; NONHUMAN; SEPTIC SHOCK; SMALL INTESTINE; SWINE; VASODILATATION;

ANIMALS; CARDIOMYOPATHIES; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUANIDINES; HEMODYNAMICS; HYPOTENSION; ISOENZYMES; LIPOPOLYSACCHARIDES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OMEGA-N-METHYLARGININE; ORGAN SPECIFICITY; SHOCK, SEPTIC; SWINE; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 44449101531     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181598b77     Document Type: Article

References (33)

1. Kilbourn RG, Griffith OW: Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 84:827-831, 1992.
2. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC: Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 259(4 Pt 2):H1038-H1043, 1990.
3. G-Monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun 178:1135-1140, 1991.
4. Sharma VS, Traylor TG, Gardiner R, Mizukami H: Reaction of nitric oxide with heme proteins and model compounds of hemoglobin. Biochemistry 26:3837-3843, 1987.
5. G-methyl-L- arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172:1132-1138, 1990.
6. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991.
7. Parker JL, Adams HR: Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res 72:539-551, 1993.
8. Thiemermann C, Vane J: Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 182:591-595, 1990.
9. Busse R, Mulsch A: Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 275:87-90, 1990.
10. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, et al.: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650, 1995.
11. Chelly JE, Doursout MF, Lechevalier T, Liang YY, Chelly F, Hartley C, Kilbourn RG: Cardiac and regional hemodynamic interactions between halothane and nitric oxide synthase activity in dogs. Anesthesiology 85:142-149, 1996.
12. Hartley CJ, Cole JS: An ultrasonic pulsed Doppler system for measuring blood flow in small vessels. J Appl Physiol 37:626-629, 1974.
13. Ishida T, Lewis RM, Hartley CJ, Entman ML, Field JB: Comparison of hepatic extraction of insulin and glucagon in conscious and anesthetized dogs. Endocrinology 112:1098-1109, 1983.
14. Doursout MF, Hartley CJ, Chelly JE: Comparison of cardiac and regional hemodynamic responses to N-methyl-L-arginine and aminoguanidine infusions in conscious pigs. J Cardiovasc Pharmacol 37:349-358, 2001.
15. Corbin JL, Reporter M: N-G-methylated arginines; a convenient preparation of N-G-methylarginine. Anal Biochem 57:310-312, 1974.
16. Radomski MW, Palmer RM, Moncada S: The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 92:639-646, 1987.
17. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976.
18. Bick RJ, Wood DE, Poindexter B, McMillin JB, Karoly A, Wang D, Bunting R, McCann T, Law GJ, Buja LM: Cytokines increase neonatal cardiac myocyte calcium concentrations: the involvement of nitric oxide and cyclic nucleotides. J Interferon Cytokine Res 19:645-653, 1999.
19. Doursout MF, Kilbourn RG, Hartley CJ, Chelly JE: Effects of N-methyl-L-arginine on cardiac and regional blood flow in a dog endotoxin shock model. J Crit Care 15:22-29, 2000.
20. Stuehr DJ, Marletta MA: Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A 82:7738-7742, 1985.
21. van den Berg C, van Amsterdam JG, Bisschop A, Piet JJ, Wemer J, de Wildt DJ: Septic shock: no correlation between plasma levels of nitric oxide metabolites and hypotension or lethality. Eur J Pharmacol 270:379-382, 1994.
22. Mehta S, Javeshghani D, Datta P, Levy RD, Magder S: Porcine endotoxemic shock is associated with increased expired nitric oxide. Crit Care Med 27:385-393, 1999.
23. Salvemini D, Seibert K, Masferrer JL, Settle SL, Currie MG, Needleman P: Nitric oxide activates the cyclooxygenase pathway in inflammation. Am J Ther 2:616-619, 1995.
24. Wedgwood S, McMullan DM, Bekker JM, Fineman JR, Black SM: Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ Res 89:357-364, 2001.
25. Rees DD, Cellek S, Palmer RM, Moncada S: Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun 173:541-547, 1990.
26. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH: Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci U S A 89:6711-6715, 1992.
27. el-Dwairi Q, Comtois A, Gou Y, Hussain SN: Endotoxin-induced skeletal muscle contractile dysfunction: contribution of nitric oxide synthases. Am J Physiol 274(3 Pt 1):C770-C779, 1998.
28. Xu J, Kim GM, Chen S, Yan P, Ahmed SH, Ku G, Beckman JS, Xu XM, Hsu CY: iNOS and nitrotyrosine expression after spinal cord injury. J Neurotrauma 18:523-532, 2001.
29. Bian K, Davis K, Kuret J, Binder L, Murad F: Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry. Am J Physiol. 277(1 Pt 2):F33-F40, 1999.
30. Wanecek M, Weitzberg E, Rudehill A, Oldner A: The endothelin system in septic and endotoxin shock. Eur J Pharmacol 407:1-15, 2000.
31. Ahlborg G, Weitzberg E, Lundberg JM: Circulating endothelin-1 reduces splanchnic and renal blood flow and splanchnic glucose production in humans. J Appl Physiol 79:141-145, 1995.
32. Laszlo F, Evans SM, Whittle BJ: Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur J Pharmacol 272:169-175, 1995.
33. 2 balance during endotoxemia in pigs. Intensive Care Med 31:985-992, 2005.